Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy | Zendy

Chanda Kulkarni | Zendy; Padmini Devi | Zendy; K Madhu | Zendy; B Ganapathy | Zendy; GRK Sarma | Zendy; Lisha Jenny John | Zendy

Open Access

Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy

Author(s) -

Chanda Kulkarni,

Padmini Devi,

K Madhu,

B Ganapathy,

GRK Sarma,

Lisha Jenny John

Publication year - 2012

Publication title -

indian journal of pharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.286

H-Index - 59

eISSN - 1998-3751

pISSN - 0253-7613

DOI - 10.4103/0253-7613.91867

Subject(s) - pregabalin , duloxetine , medicine , gabapentin , visual analogue scale , clinical global impression , adverse effect , neuropathic pain , anesthesia , peripheral neuropathy , repeated measures design , diabetes mellitus , placebo , statistics , alternative medicine , mathematics , pathology , endocrinology

To compare the efficacy and safety of gabapentin (GBP), duloxetine (DLX), and pregabalin (PGB) in patients with painful diabetic peripheral neuropathy (DPNP).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research